Monsenso A/S (MONSO.CO)
Monsenso A/S operates in the Medical - Healthcare Information Services industry of the Healthcare sector, headquartered in Frederiksberg, ZE, DK. The stock last traded at $0.29, up 0.00% on the session, giving a market capitalisation of $19.4M. Its beta of 1.09 implies it has historically moved more than the broad market.
Monsenso A/S, established in Copenhagen, Denmark in 2013, specializes in developing and marketing digital health solutions for the treatment of mental disorders. The company offers a multi-faceted platform, including a dedicated Monsenso app for individuals, which assists users with self-assessments, questionnaires, sensor data collection from personal devices, medication and session reminders, visual progress tracking, motivational feedback, and psychoeducation incorporating cognitive behavioral therapy. A separate application is available for caregivers, providing self-assessment tools, questionnaires, educational content, and various learning resources. For healthcare professionals, Monsenso provides a clinical web portal designed for visualizing patient data, managing patient dashboards, reviewing historical overviews, conducting correlation analysis, facilitating secure messaging, supporting shared decision-making, and maintaining medical records. Additionally, clinicians have access to data analytics features, enabling the aggregation of historical health and behavioral data, statistical descriptions, analysis of correlations between behavior and illness progression, pattern identification, predictive mood forecasting, and risk assessment. The company's innovative tools are utilized by patients, their caregivers, clinical staff, healthcare systems, and researchers.
Monsenso A/S is most often compared with the following Healthcare names: